'3-in-1' hypertension pill offers better success: Study

Image
IANS Canberra
Last Updated : Aug 15 2018 | 10:55 AM IST

With over a billion people struggling to control their high blood pressure globally, an Australian study suggests a "three-in-one" pill for better results.

The trial involved three drugs, each at half dose, in a single pill for early treatment. It met with success in 70 per cent of the cases in a targeted group, the George Institute for Global Health (GIGH) said on Wednesday.

In conventional medication, patients are treated with one drug at a very low dose, which is increased over time with additional drugs added and increased in dosage to try to reach targets.

However, the Australian-led trials showed that low-dose of the "three-in-one" pill helped almost three-fourth patients to lower their blood pressure compared to just around half receiving normal care, Xinhua news agency reported.

"Our results could help millions reduce their risk of heart attack or stroke," said Ruth Webster of GIGH said. The study was published in JAMA, a journal of the American Medical Association.

The findings could impact guidelines on treating hypertension globally, said the institute.

--IANS

in/sed

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 15 2018 | 10:46 AM IST

Next Story